| (P341) |
Vascular endothelial growth factor is increased by inflammatory cytokines Interleukin-6 and Oncostatin M in human adipose tissue-derived stem cells. |
|
G. Rega, Chr. Kaun, T. Weiss, Ph. Hohensinner, S. Demyanets, R. Roehle, M. Frey, G. Maurer, K. Huber, J. Wojta (Vienna, AT) |
| (P342) |
Molecular mechanisms regulating the mobilization of neutrophils from the bone marrow. |
|
S. Rankin, C. Martin, P. Burdon (London, GB) |
| (P343) |
Inflammatory cytokines interleukin-6 and oncostatin M increase vascular endothelial growth factor in human adipose tissue. |
|
G. Rega, Chr. Kaun, T. Weiss, Ph. Hohensinner, S. Demyanets, R. Roehle, M. Frey, G. Maurer, K. Huber, J. Wojta (Vienna, AT) |
| (P344) |
Role of inflammation on dendritic cells and vascular smooth muscle cell interactions. |
|
M.C. Vinci, L. Bellik, F. Ledda, A. Parenti (Florence, IT) |
| (P345) |
Increased levels of IgG1 against an aldehyde-modified peptide sequence in apo B–100 is associated with decreased severity of carotid stenosis. |
|
G.N. Fredrikson, G. Berglund, R. Alm, J-Å. Nilsson, A. Schiopu, P.K. Shah, J. Nilsson, the participants in this study (Malmö, SE; Los Angeles, US) |
| (P346) |
The CD40-TRAF6 axis is the key-regulator of the CD40-CD40L system in neointima formation. |
|
M. Donners, L. Beckers, R. Noelle, M. Daemen, E. Lutgens (Maastricht, NL; Hanover, US) |
| (P347) |
Hepatocyte growth factor mediates induction of PAI-1, Il-6 and Il-8 in human adipose tissue. |
|
G. Rega, Chr. Kaun, T. Weiss, S. Demyanets, M. Frey, G. Maurer, K. Huber, J. Wojta (Vienna, AT) |
| (P348) |
Platelet activating factor acetylhydrolase is not involved in the liberation of 8-iso-Prostaglandin F2α: A case-control study. |
|
G.D. Kom, E. Schwedhelm, R. Maas, L. Schneider, R.A. Benndorf, R.H. Böger (Hamburg, DE) |
| (P349) |
Influence of the platelet activating factor (PAF) - PAF-receptor - system on vascular changes and inflammation: effects in a murine model of acute lung injury (ALI). |
|
J. Ott, M. Schaefer, M.H. Bi, A. Mohr, S. Ishii, T. Shimizu, F. Grimminger, W. Seeger, K. Mayer (Gießen, DE; Tokyo, JP) |
| (P350) |
Inflammatory response and apoptosis induction after vascular brachytherapy: role of the peroxynitrite-poly(ADP-ribose) polymerase pathway. |
|
C.J. Beller, E. Horvath, J. Kosse, L. Seres, T. Radovits, R. Krempien, I. Berger, S. Hagl, C. Szabó, G. Szabó (Heidelberg, DE; Budapest, HU) |
| (P351) |
Propionate and butyrate inhibit oxidised LDL-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells. |
|
M. Naruszewicz, A. Siennicka, D. Zapolska-Downar (Szczecin, PL) |
| (P352) |
Inhibitor of differentiation Id2 is involved in the pathogenesis of angiotensin II-induced end-organ damage. |
|
P. Gratze, R. Dechend, E. Shagdarsuren, J-K. Park, M. Wellner, A. Fiebeler, A. Zenclusen, N. Alenina, M. Bader, M. Zenke, F.C. Luft, D.N. Mueller (Berlin, Hannover and Aachen, DE) |
| (P353) |
Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells. |
|
M. Fritzenwanger, F. Kuethe, H.R. Figulla (Jena, DE) |
| (P354) |
TF-induced endothelial cell apoptosis is mediated via the p53 pathway. |
|
A. Pradier, C. Ettelaie (Hull, GB) |
| (P355) |
Inosine protects against myocardial and endothelial reperfusion injury after heart transplantation. |
|
G. Szabó, N. Stumpf, L. Seres, H. Siegfried (Heidelberg, DE) |